معرفی
Dr. Max Noble is an Honorary Fellow at the University of York's Department of Biology. He serves as CEO of VISFO, a UK-based health technology firm. With over 30 years in healthcare industries, his expertise spans health outcomes research, pharmacoepidemiology, advanced health economic methodologies (e.g., discrete choice experiments), and software development. He leads a 40-member interdisciplinary team in clinical and real-world evidence development, collaborating with pharmaceutical firms, medical device companies, and academia.
- Education: Medicinal Chemistry, Chemical Engineering (University of Manchester), Health Economics (University of York).
Research & Impact
Focus areas include health technology assessment, launch excellence, and software-driven solutions for healthcare. His team integrates statistics, machine learning, and biomedical science to advance evidence-based practices.
Advancing Education
- Funded 18 undergraduates via the Enigma Scholarship (York's widening participation initiative).
- Sponsored two MRes students studying inflammasomes in Lupus mechanisms.
- Spearheading an industrial PhD in Psychology (misinformation studies) and collaborative projects with Dr. Jillian Barlow under Generation Research.
Career Contributions
Prior roles include clinical experience at Glaxo-Wellcome and work in SmithKline Beecham’s Global Pricing & Health Economics group. Engages with York’s careers department through IntoTech and STEM career programs.
